mars bioimaging ltd spectral ct for biomedical imaging anthony butler
TRANSCRIPT
MARS Bioimaging Ltd
spectral CT for biomedical imaging
Anthony Butler
www.marsbioimaing.com
Founded 2008:
Spin out of University of Canterbury
Exclusive licence for CERN Medipix3 detector technology
Own all IP relating spectral CT from the university
Products:
MARS scanners: Medipix3 based microCT system
MARS camera: Medipix3 detector and readout for integration into 3rd party CTs
Overview
Technology and its uses
Xray source
MAR
S sp
ectr
al C
T
Medipix
Colordetectors
Spectral CT is now possible
Medipix All Resolution System
Energy resolution
Spatial resolution
Temporal resolution
Cartilage
Bone
Low GAG
MBI Products
MARS scanner
microCT for small animal and pathology researcher
MARS Medipix3 camera
Up to 8 Simultaneous energies
55µm or 110 µm pixel pitch resolution
1 to 6 Medipix chips (28x52mm array)
Silicon or CdTe/CZT
Excellent energy resolution ( Charge sharing compensation )
Image of PCB taken with Medipix3 Si-quad, 28x28mm
Medipix3 camera system
for integration into 3rd party systems
MBI Company information
Market strategy
Get MARS systems to key opinion leader’s labs
Enable researchers using MARS tool to validate spectral CT
Provide camera units for existing pre-clinical manufacturers to integrate into their systems
Leverage pre-clinical adoption to find partner for human imaging
MARS project structure
MARS is the technology
MARS Bioimaging Ltdaka. “MBI”
Commercial outlet for NZ’s R+D
Research teamsUniversity of Canterbury
University of Otago
MARS project structure
MARS Bioimaging Ltdaka. “MBI”
Commercial outlet for NZ’s R+D
Shareholders University of Canterbury Individual scientist Private investors
MARS IP structure
MARS Bioimaging Ltd
Medipix3 Collaboration
University of Canterbury
University of Otago
Exclusive license forsmall animal and human CT
All IP relating to spectral CTtechnology
Sub-contract for pre-clinical research
MARS Funding structure
MARS Bioimaging Ltd
Medipix3 Collaboration
University of Canterbury
University of Otago
Investment
MARS Funding structure
MARS Bioimaging Ltd
Medipix3 Collaboration
University of Canterbury
University of Otago
InvestmentSales
MARS Funding structure
MARS Bioimaging Ltd
Medipix3 Collaboration
University of Canterbury
University of Otago
InvestmentSales
Contribution to Medipix3 development
Scholarship funding
MARS Funding structure
MARS Bioimaging Ltd
Medipix3 Collaboration
University of Canterbury
University of Otago
InvestmentSales
Scholarship funding
NZ government funding
Contribution to Medipix3 development
Why would a researcher do this?
Government instruction
80% of NZ government funding is aimed at economic return
Key concept is international revenue
Want a route to market early in an R+D program
Benefit to research
Provides direction and focus
Get the technology into users hands early
Provides new funding routes
Personal
Satisfaction – your research is used!!!
New challenges
Personal
Satisfaction – your research is used!!!
New challenges
Potential for financial gain…
…. but I’m a radiologist!!
Summary
MARS-CT make spectral CT possible
Early adopters already purchasing
www.marsbioimaging.com